NHS Pharmaceuticals 2016_1
key details
| Value | £55,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West |
| Deadline | 9 Jun 2016 |
| Contract start | 1 Dec 2016 |
| Contract end | 30 Jun 2018 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-a23635c0-adc9-11e6-9901-0019b9f3037b |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Please see attachments for list of awarded suppliers | £50,000,000 | 18 Sept 2016 | active |
description
NHS Pharmaceuticals 2016_1
CM/PHG/12/5378
Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 38 months Potential periods of call-offs under the framework agreement:
Central, South Central and South West: 01/12/2016 to 30/06/2018 (19 months)
South East, South London, North East
and Yorkshire: 01/12/2016 to 31/01/2018 (14 months)
Eastern, North London and North West: 01/12/2016 to 30/06/2017 (7 months)
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 30 Jan 2015 | Planning (planning) | · | ocds-b5fd17-3001708e-adc8-11e6-9901-0019b9f3037b-59855-cm-phg-12-5378 |
| 23 Jun 2015 | Planning (planning) | · | ocds-b5fd17-8318da17-adc8-11e6-9901-0019b9f3037b-67593-cm-phg-12-5378-w |
| 18 Nov 2016 | Award (award) | · | 30beb2b7-168b-466b-b46d-9cf9a67aaf98-95966 |
more from COMMERCIAL MEDICINES UNIT
- NHS Framework Agreement for Branded Pharmaceuticals - North of England Tranche A. · £575,675,600 · 24 Apr 2017
- NHS Framework Agreement for the Midlands and East Pharmacy Purchasing Group for the supply of Proprietary Pharmaceuticals - Tranche B · £102,379,487 · 24 Apr 2017
- Contract for the supply of BCG vaccine · 9 Jan 2017
- Contract for the supply of human papillomavrius vaccine · 22 Dec 2016
- NHS National Pharmaceuticals - Wave 10c Offer reference number: CM/PHG/15/5466 Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 40 months. Potential periods of call-offs under the framework agreement: Oral Products: All Regions 01/07/2017 to 28/02/2019 (20 months) Hospital Only Products: Central and South West (CESW) 01/07/2017 to 30/06/2018 (12 months); North West and Eastern and North London (NWLN) 01/07/2017 to 30/06/2018 (12 months) and South East and South London and North East and Yorkshire (LSNE) 01/07/2017 to 30/06/2018 (12 months) · £182,500,000 · 16 Dec 2016
- NHS Framework Agreement for Hepatitis C Medicines for Midlands and East and North of England regions · £85,000,000 · 25 Nov 2016
- Invitation to offer for NHS Framework Agreement for Branded Pharmaceuticals for London – Tranche A (inc. Hepatitis C) · £201,544,684 · 18 Nov 2016
- Contract for the supply of BCG vaccine · 18 Nov 2016
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.